Propel Bio Management, LLC
- SEC CIK
- 0001969764
- Latest filing
- Aug 13, 2026
TRVI holding history
Trevi Therapeutics, Inc. in every 13F filed by Propel Bio Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TRVI overviewAll 13F holders of TRVIFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −223,802−100.0% | Sold out | Holders |
| Q1 2026 | 223,802 | $2.65M | 1.7% | +223,802 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −260,000−100.0% | Sold out | Holders |
| Q2 2024 | 260,000 | $774.8K | 0.5% | 00.0% | Unchanged | Holders |
| Q1 2024 | 260,000 | $897.0K | 0.5% | +260,000 | New | Holders |